15 Results for "

Chlamydia trachomatis

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "Chlamydia trachomatis" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B0643
CAS No.: 62013-04-1
Synonyms: LY237216
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Dirithromycin (LY237216), a derivative of Erythromycin, is a potent and orally active semi-synthetic macrolide antibiotic. Dirithromycin is active against gram-positive bacteria, Legionella spp., Helicobacter pylori, and Chlamydia trachomatis .
loading...
    loading...
Cat. No.: HY-105099
CAS No.: 129791-92-0
Purity:  99.64%
Synonyms: KRM-1648; ABI-1648
Rifalazil (KRM-1648; ABI-1648), a rifamycin derivative, inhibits the bacterial DNA-dependent RNA polymerase and kills bacterial cells by blocking off the β-subunit in RNA polymerase . Rifalazil (KRM-1648; ABI-1648) is an antibiotic, exhibits high potency against mycobacteria, gram-positive bacteria, Helicobacter pylori, C. pneumoniae and C. trachomatis with MIC values from 0.00025 to 0.0025 μg/ml . Rifalazil (KRM-1648; ABI-1648) has the potential for the treatment of Chlamydia infection, Clostridium difficile associated diarrhea (CDAD), and tuberculosis (TB) .
loading...
    loading...
Cat. No.: HY-P11211
CAS No.: 172263-89-7
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

D2A21, a cecropin peptide, demonstrates a minimum cidal concentration of 21.69 μg/mL against Chlamydia trachomatis .
loading...
    loading...
Cat. No.: HY-D1574
CAS No.: 94885-04-8
C6 NBD Sphingomyelin is a fluorescent short-chain analogue of Sphingomyelin (HY-113498). Chlamydia trachomatis acquires C6 NBD Sphingomyelin endogenously synthesizes from C6-NBD-ceramide and transportes to the chlamydial inclusion. C6 NBD Sphingomyelin can incorporate into the plasma membrane .
loading...
    loading...
Cat. No.: HY-144820
CAS No.: 130727-21-8
Purity:  98.49%
Research Areas:  

Infection

JO146 is an anti-chlamydial agent, Antibacterial agent, and CtHtrA serine protease inhibitor, with an IC50 of 21.86 μM against CtHtrA serine protease. JO146 alters the morphology of chlamydial cells, reduces inclusion vacuoles, decreases the number of infectious progeny, and eliminates viable Chlamydia trachomatis under stress or conditions that reverse persistent infection. JO146 shows no activity against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus, but exhibits bactericidal activity against Helicobacter pylori. JO146 can be used in research related to Chlamydia trachomatis infection, chlamydial infection in cattle and sheep, and Helicobacter pylori infection .
loading...
    loading...
Cat. No.: HY-136885
CAS No.: 143457-40-3
Target:  

MMP

Research Areas:  

Infection

(S,S)-TAPI-0 is a matrix metalloproteinase (MMP) inhibitor that inhibits the growth of Chlamydia trachomatis by inhibiting PDF enzyme activity. (S,S)-TAPI-0 can be used to study Chlamydia infection .
loading...
    loading...
Cat. No.: HY-120450
CAS No.: 1370706-59-4
Target:  

Bacterial

Research Areas:  

Infection Inflammation/Immunology

CL-55 is an inhibitor for type three secretion system of Chlamydia trachomatis, that blocks the effector molecules delivery of bacteria into host cells. CL-55 ameliorates the C. trachomatis infection and inflammation in mice .
loading...
    loading...
Cat. No.: HY-172220
Research Areas:  

Infection

ChlaDUB1-IN-2 (Compound 27a) is the inhibitor for Chlamydia trachomatis deubiquitinase ChlaDUB1 with an IC50 of 0.97 μM. ChlaDUB1-IN-2 inhibits the inclusion body formation of C. trachomatis with an IIC50 of 25.6 μg/mL .
loading...
    loading...
Cat. No.: HY-181614
CAS No.: 28505-57-9
Target:  

Bacterial

Research Areas:  

Infection

CppA-IN-1 is a CppA inhibitor specific to Chlamydia trachomatis, which inhibits the growth of Chlamydia trachomatis. CppA-IN-1 shows no activity against recombinant CppA in vitro. CppA-IN-1 can be used in studies related to Chlamydia trachomatis infection .
loading...
    loading...
Cat. No.: HY-117746
CAS No.: 1638100-63-6
Target:  

Bacterial

Research Areas:  

Infection

KSK120 is a potent inhibitor of drug-resistant infections with specific activity against Chlamydia trachomatis (C. trachomatis). KSK120 inhibits the developmental cycle of C. trachomatis, thereby reducing the infectivity of progeny bacteria. KSK120 targets the glucose-6-phosphate (G-6P) metabolic pathway of C. trachomatis, showing its potential application in antimicrobial inhibition. The mechanism of KSK120 may involve inhibition of the transcriptional machinery, which provides new ideas for the development of specific drugs against C. trachomatis infection .
loading...
    loading...
Cat. No.: HY-B0643R
CAS No.: 62013-04-1
Synonyms: LY237216 (Standard)
Research Areas:  

Infection

Dirithromycin (Standard) is the analytical standard of Dirithromycin. This product is intended for research and analytical applications. Dirithromycin (LY237216), a derivative of Erythromycin, is a potent and orally active semi-synthetic macrolide antibiotic. Dirithromycin is active against gram-positive bacteria, Legionella spp., Helicobacter pylori, and Chlamydia trachomatis .
loading...
    loading...
Cat. No.: HY-105099R
CAS No.: 129791-92-0
Synonyms: KRM-1648 (Standard); ABI-1648 (Standard)
Rifalazil (Standard) is the analytical standard of Rifalazil. This product is intended for research and analytical applications. Rifalazil (KRM-1648; ABI-1648), a rifamycin derivative, inhibits the bacterial DNA-dependent RNA polymerase and kills bacterial cells by blocking off the β-subunit in RNA polymerase[1]. Rifalazil (KRM-1648; ABI-1648) is an antibiotic, exhibits high potency against mycobacteria, gram-positive bacteria, Helicobacter pylori, C. pneumoniae and C. trachomatis with MIC values from 0.00025 to 0.0025 μg/ml[3]. Rifalazil (KRM-1648; ABI-1648) has the potential for the treatment of Chlamydia infection, Clostridium difficile associated diarrhea (CDAD), and tuberculosis (TB)[2].
loading...
    loading...
Cat. No.: HY-P704054
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Major outer membrane porin, serovar B; MOMP; ompA; omp1B; Chlamydia trachomatis
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-W683763
CAS No.: 167887-97-0
Synonyms: HSR-903 free base
Target:  

Bacterial

Research Areas:  

Infection

Olamufloxacin (HSR-903) is an orally active fluoroquinolone antibacterial agent. Olamufloxacin inhibits DNA supercoiling activity. Olamufloxacin exhibits activity against Gram-positive, Gram-negative, chlamydial, and quinolone-resistant bacterial strains. Olamufloxacin can be used for the research of bacterial infections .
loading...
    loading...
Cat. No.: HY-W683763A
CAS No.: 167888-07-5
Synonyms: HSR-903
Target:  

Bacterial

Research Areas:  

Infection

Olamufloxacin (HSR-903) methanesulfonate is an orally active fluoroquinolone antibacterial agent. Olamufloxacin methanesulfonate inhibits DNA supercoiling activity. Olamufloxacin methanesulfonate exhibits activity against Gram-positive, Gram-negative, chlamydial, and quinolone-resistant bacterial strains. Olamufloxacin methanesulfonate can be used for the research of bacterial infections .
loading...
    loading...
  • 1